Overview

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
In this trial the safety, tolerability, pharmacokinetics and exploratory pharmacodynamics of multiple dose administration of BI 144807 will be investigated in otherwise healthy, controlled asthmatic patients
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim